Chih-Yuan Lee

5PUBLICATIONS
18CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 05, 2026
Zfand5 terminates TLR3/4 signaling and necroptosis by targeting TRIF to the proteasome for degradation.

|Mar 28, 2026
ZNRF1 deficiency disrupts Fas ligand trafficking and immune balance.

Ting-Yu Lai, Yung-Chi Chang, You-Sheng Lin

|Mar 27, 2025
Chronic Antibody-Mediated Rejection and Plasma Cell ER Stress: Opportunities and Challenges with Calcineurin Inhibitors.

Ching-Yi Tsai, Chih-Yuan Lee, Jia-Huang Chen

|May 09, 2023
The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage.

You-Sheng Lin, Yung-Chi Chang, Tai-Ling Chao

|Aug 10, 2021
The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.

Pin-Jui Kung, Ting-Yu Lai, Jerry Cao

Pageof 1

Frequent Collaborators

3 joint publications

Li-Chung Hsu

2 joint publications

Yung-Chi Chang

1 joint publications

You-Sheng Lin

1 joint publications

Tai-Ling Chao